CHLORPHENIRAMINE MALEATE

CHLORPHENIRAMINE MALEATE was reported 50657 times

CHLORPHENIRAMINE MALEATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTACID THERAPY 18 0.1385
1 HIV ASSOCIATED NEPHROPATHY 7 0.1373
2 SLEEP DISORDER THERAPY 27 0.1364
3 DELUSION OF GRANDEUR 61 0.1359
4 POLYGLANDULAR DISORDER 9 0.1324
5 EROSIVE PUSTULAR DERMATOSIS 6 0.1200
6 LIVER GRAFT LOSS 5 0.1163
7 NECROTIC LYMPHADENOPATHY 12 0.1000
8 APPENDICOLITH 38 0.0982
9 ANALGESIC THERAPY 26 0.0810
10 DRUG THERAPY 26 0.0767
11 BRONCHIAL NEOPLASM 9 0.0662
12 BACTEROIDES INFECTION 17 0.0651
13 ANTICOAGULANT THERAPY 18 0.0634
14 DILATATION INTRAHEPATIC DUCT ACQUIRED 18 0.0616
15 DELUSION OF REPLACEMENT 6 0.0600
16 CONGENITAL HIATUS HERNIA 11 0.0482
17 ANAEMIA FOLATE DEFICIENCY 9 0.0466
18 CONFUSIONAL AROUSAL 7 0.0435
19 LYMPHOCYTE COUNT ABNORMAL 48 0.0426
20 CATHETER SITE BRUISE 13 0.0393
21 MALIGNANT MELANOMA STAGE 0 8 0.0383
22 VASCULAR COMPRESSION 12 0.0380
23 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 29 0.0306
24 BRONCHIAL HAEMORRHAGE 9 0.0288
25 NASAL TURBINATE HYPERTROPHY 10 0.0265
26 RENAL ISCHAEMIA 14 0.0256
27 ENDOMETRIAL ABLATION 9 0.0252
28 NAIL DYSTROPHY 12 0.0214
29 NEUTROPENIC INFECTION 19 0.0199
30 RHINALGIA 52 0.0189
31 HYPERPHOSPHATAEMIA 35 0.0163
32 EXCESSIVE EYE BLINKING 23 0.0156
33 HAEMOPERITONEUM 12 0.0150
34 TERMINAL ILEITIS 9 0.0147
35 TOTAL LUNG CAPACITY DECREASED 23 0.0144
36 ENCEPHALITIS CYTOMEGALOVIRUS 6 0.0137
37 BLOOD PHOSPHORUS INCREASED 35 0.0128
38 NAIL INFECTION 18 0.0126
39 HYPOPARATHYROIDISM 9 0.0117
40 AXILLARY PAIN 17 0.0114
41 CHRONIC HEPATITIS 9 0.0111
42 NECROTISING COLITIS 14 0.0110
43 PRODUCT USED FOR UNKNOWN INDICATION 13 0.0103
44 STASIS DERMATITIS 7 0.0102
45 GALLBLADDER POLYP 8 0.0102
46 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 9 0.0097
47 NEUTROPENIC SEPSIS 67 0.0094
48 AFFECTIVE DISORDER 73 0.0093
49 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 6 0.0091
50 LUNG OPACITY 24 0.0091
51 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 10 0.0080
52 EXPOSURE TO TOXIC AGENT 24 0.0075
53 SINUSITIS FUNGAL 6 0.0075
54 AORTIC STENOSIS 26 0.0075
55 ENDOCRINE DISORDER 9 0.0070
56 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 35 0.0069
57 CANDIDA SEPSIS 6 0.0067
58 BLOOD URIC ACID INCREASED 38 0.0066
59 RHONCHI 9 0.0065
60 HYPERTROPHIC CARDIOMYOPATHY 10 0.0065
61 NEUTROPHIL COUNT INCREASED 66 0.0064
62 HYPOPHOSPHATAEMIA 47 0.0064
63 CYTOMEGALOVIRUS TEST POSITIVE 11 0.0062
64 ERYTHRODERMIC PSORIASIS 5 0.0061
65 IRON DEFICIENCY 27 0.0060
66 VITILIGO 14 0.0060
67 APPENDICITIS 55 0.0059
68 BRONCHIAL DISORDER 9 0.0058
69 MUCOSAL INFLAMMATION 150 0.0057
70 CATHETER SITE HAEMORRHAGE 14 0.0056
71 BAND SENSATION 7 0.0055
72 IMPETIGO 8 0.0054
73 AUTOIMMUNE HAEMOLYTIC ANAEMIA 18 0.0052
74 PO2 DECREASED 6 0.0052
75 SCHIZOPHRENIA 63 0.0052
76 PANCREATITIS CHRONIC 12 0.0051
77 ONYCHALGIA 5 0.0050
78 MYASTHENIA GRAVIS 40 0.0049
79 DIVERTICULAR PERFORATION 10 0.0049
80 TOXIC EPIDERMAL NECROLYSIS 72 0.0047
81 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 13 0.0047
82 EJECTION FRACTION DECREASED 72 0.0046
83 VULVOVAGINAL CANDIDIASIS 6 0.0044
84 TOXIC ENCEPHALOPATHY 22 0.0043
85 HYPOCHLORAEMIA 5 0.0043
86 POOR PERIPHERAL CIRCULATION 18 0.0042
87 VOLVULUS 10 0.0042
88 CD4 LYMPHOCYTES DECREASED 9 0.0042
89 GASTRIC DILATATION 7 0.0042
90 VENTRICULAR FIBRILLATION 46 0.0041
91 LYMPHOCYTE COUNT DECREASED 73 0.0041
92 LIMB MASS 9 0.0041
93 INFUSION SITE INDURATION 6 0.0040
94 HALLUCINATION, AUDITORY 64 0.0040
95 SARS-COV-2 TEST POSITIVE 53 0.0040
96 DEEP VEIN THROMBOSIS POSTOPERATIVE 8 0.0040
97 INDURATION 7 0.0039
98 CANCER PAIN 10 0.0039
99 STAPHYLOCOCCAL SEPSIS 19 0.0038
100 SOFT TISSUE INFECTION 7 0.0038
101 PARADOXICAL DRUG REACTION 14 0.0038
102 TROPONIN INCREASED 28 0.0037
103 VENOOCCLUSIVE LIVER DISEASE 18 0.0036
104 VENOOCCLUSIVE DISEASE 9 0.0036
105 FEBRILE NEUTROPENIA 236 0.0036
106 NAIL DISORDER 31 0.0035
107 READING DISORDER 8 0.0035
108 LOWER RESPIRATORY TRACT INFECTION 159 0.0035
109 ABDOMINAL MASS 9 0.0034
110 CYTOKINE RELEASE SYNDROME 67 0.0033
111 LUNG ADENOCARCINOMA 10 0.0033
112 PEMPHIGOID 25 0.0033
113 BLOOD CALCIUM INCREASED 29 0.0033
114 RALES 19 0.0033
115 PLEURITIC PAIN 9 0.0033
116 BREATH SOUNDS ABNORMAL 16 0.0032
117 INFUSION SITE BRUISING 7 0.0032
118 SPUTUM INCREASED 7 0.0032
119 ONYCHOLYSIS 5 0.0032
120 RENAL TUBULAR DISORDER 9 0.0032
121 SINUS TACHYCARDIA 45 0.0032
122 CARDIOGENIC SHOCK 45 0.0031
123 ANALGESIC DRUG LEVEL INCREASED 5 0.0031
124 BENIGN PROSTATIC HYPERPLASIA 16 0.0031
125 NEUROPATHY PERIPHERAL 291 0.0031
126 RESPIRATORY TRACT INFECTION VIRAL 7 0.0030
127 GAMBLING DISORDER 8 0.0030
128 CYTOMEGALOVIRUS INFECTION REACTIVATION 13 0.0029
129 RECTAL CANCER 9 0.0029
130 BLOOD PH DECREASED 5 0.0029
131 HICCUPS 24 0.0029
132 BRAIN DEATH 9 0.0029
133 ILEUS PARALYTIC 13 0.0029
134 CAPILLARY LEAK SYNDROME 6 0.0029
135 EXTRAPYRAMIDAL DISORDER 72 0.0029
136 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 6 0.0029
137 SERUM SICKNESS 8 0.0029
138 LOGORRHOEA 10 0.0028
139 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 5 0.0028
140 DEVICE INFUSION ISSUE 7 0.0028
141 MULTIPLE DRUG OVERDOSE INTENTIONAL 9 0.0028
142 LIVER TRANSPLANT REJECTION 5 0.0028
143 SKIN ABRASION 13 0.0027
144 INFUSION SITE HAEMORRHAGE 9 0.0027
145 AMYLASE INCREASED 10 0.0027
146 LEFT VENTRICULAR DYSFUNCTION 18 0.0027
147 INFUSION SITE REACTION 8 0.0027
148 HYPERLIPIDAEMIA 32 0.0027
149 BLOOD MAGNESIUM DECREASED 23 0.0027
150 DISLOCATION OF VERTEBRA 6 0.0026
151 DYSAESTHESIA 8 0.0026
152 LARYNGOSPASM 7 0.0026
153 GRANULOMA 9 0.0026
154 BACTERIAL INFECTION 48 0.0026
155 ASCITES 75 0.0025
156 INFUSION SITE PRURITUS 8 0.0025
157 CONJUNCTIVAL HYPERAEMIA 9 0.0025
158 NEURALGIA 61 0.0025
159 LUNG CONSOLIDATION 7 0.0025
160 BLOOD TEST ABNORMAL 35 0.0025
161 RESPIRATORY SYMPTOM 7 0.0025
162 NEUTROPHIL COUNT DECREASED 100 0.0025
163 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 42 0.0024
164 LARYNGEAL OEDEMA 15 0.0024
165 IMPULSIVE BEHAVIOUR 9 0.0024
166 INFUSION RELATED REACTION 157 0.0024
167 RHINITIS 19 0.0024
168 CARBOHYDRATE ANTIGEN 125 INCREASED 8 0.0023
169 SEASONAL ALLERGY 33 0.0023
170 PUSTULAR PSORIASIS 8 0.0023
171 PARONYCHIA 10 0.0023
172 HYPOKALAEMIA 105 0.0023
173 HYPONATRAEMIA 128 0.0023
174 ENTEROCOLITIS 13 0.0022
175 PSYCHOTIC DISORDER 66 0.0022
176 ELECTROENCEPHALOGRAM ABNORMAL 7 0.0022
177 VISUAL FIELD DEFECT 16 0.0022
178 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 13 0.0022
179 NEUTROPENIA 296 0.0022
180 NASAL DISCOMFORT 17 0.0021
181 CELLULITIS 108 0.0021
182 SKIN TOXICITY 12 0.0021
183 COVID-19 PNEUMONIA 25 0.0021
184 OLIGURIA 13 0.0021
185 HYPOMAGNESAEMIA 29 0.0021
186 INFUSION SITE SWELLING 13 0.0021
187 FAECES HARD 8 0.0021
188 BLOOD BILIRUBIN INCREASED 55 0.0020
189 NAIL DISCOLOURATION 8 0.0020
190 RHINITIS ALLERGIC 9 0.0020
191 DERMATITIS CONTACT 23 0.0020
192 INFUSION SITE ERYTHEMA 17 0.0020
193 MULTIPLE DRUG OVERDOSE 10 0.0020
194 HYPERNATRAEMIA 10 0.0020
195 AZOTAEMIA 8 0.0020
196 VASCULAR DEVICE INFECTION 9 0.0020
197 LIP SWELLING 66 0.0020
198 URINE ABNORMALITY 9 0.0020
199 DERMATITIS ACNEIFORM 12 0.0020
200 DYSCHEZIA 6 0.0020
201 NEOPLASM PROGRESSION 67 0.0019
202 MULTIPLE ORGAN DYSFUNCTION SYNDROME 54 0.0019
203 BRONCHOSPASM 27 0.0019
204 ULCER 30 0.0019
205 CUSHINGOID 6 0.0019
206 VENTRICULAR HYPOKINESIA 6 0.0019
207 ALCOHOL POISONING 5 0.0019
208 RETINAL DETACHMENT 17 0.0018
209 ALANINE AMINOTRANSFERASE INCREASED 113 0.0018
210 DISEASE PROGRESSION 217 0.0018
211 CLUMSINESS 5 0.0018
212 LEUKOCYTOSIS 33 0.0018
213 RESPIRATORY RATE INCREASED 16 0.0018
214 OBSTRUCTIVE AIRWAYS DISORDER 20 0.0018
215 SPINAL CORD COMPRESSION 7 0.0018
216 PLANTAR FASCIITIS 6 0.0018
217 MULTIPLE ALLERGIES 14 0.0018
218 RASH PUSTULAR 13 0.0018
219 SUSPECTED OFF LABEL USE 8 0.0018
220 PRESYNCOPE 43 0.0018
221 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 9 0.0018
222 PLATELET COUNT DECREASED 188 0.0018
223 DRUG TOXICITY 24 0.0018
224 ATRIAL FLUTTER 14 0.0018
225 ACUTE GRAFT VERSUS HOST DISEASE 8 0.0017
226 HYDRONEPHROSIS 13 0.0017
227 PERIORBITAL OEDEMA 9 0.0017
228 HAEMOPTYSIS 48 0.0017
229 ANAPHYLACTIC REACTION 95 0.0017
230 LEUKOPENIA 86 0.0017
231 PERFORMANCE STATUS DECREASED 8 0.0017
232 THROMBOPHLEBITIS 6 0.0017
233 INFUSION SITE PAIN 22 0.0017
234 HYPERURICAEMIA 7 0.0017
235 EAR PAIN 33 0.0017
236 BRAIN HERNIATION 5 0.0017
237 HYPOALBUMINAEMIA 13 0.0017
238 HEPATOTOXICITY 37 0.0017
239 BLOOD SODIUM DECREASED 31 0.0016
240 SENSITIVE SKIN 12 0.0016
241 RASH MACULO-PAPULAR 36 0.0016
242 GOUT 29 0.0016
243 CHRONIC SINUSITIS 6 0.0016
244 DECUBITUS ULCER 13 0.0016
245 BRAIN OEDEMA 20 0.0016
246 ESCHERICHIA INFECTION 13 0.0016
247 NON-CARDIAC CHEST PAIN 5 0.0016
248 GASTROENTERITIS 23 0.0016
249 TONGUE OEDEMA 6 0.0016
250 LACRIMATION INCREASED 47 0.0016
251 HAEMORRHOIDS 30 0.0015
252 FACET JOINT SYNDROME 5 0.0015
253 ORAL INFECTION 6 0.0015
254 LYMPHOCYTE COUNT INCREASED 5 0.0015
255 VENOUS THROMBOSIS 6 0.0015
256 FOLLICULITIS 16 0.0015
257 FLUSHING 155 0.0015
258 BLOOD LACTIC ACID INCREASED 8 0.0015
259 IRON DEFICIENCY ANAEMIA 14 0.0015
260 PLEURAL EFFUSION 92 0.0015
261 ARTERIOSCLEROSIS CORONARY ARTERY 10 0.0015
262 ASPARTATE AMINOTRANSFERASE INCREASED 80 0.0015
263 SWELLING FACE 98 0.0015
264 FEELING OF DESPAIR 7 0.0015
265 ERYTHEMA MULTIFORME 14 0.0015
266 TACHYCARDIA 133 0.0015
267 END STAGE RENAL DISEASE 27 0.0015
268 SWOLLEN TONGUE 46 0.0015
269 SUBCUTANEOUS ABSCESS 7 0.0015
270 BRONCHOPNEUMONIA 5 0.0015
271 ANAPHYLACTOID REACTION 6 0.0015
272 THROMBOCYTOPENIA 163 0.0015
273 GENERALISED OEDEMA 18 0.0015
274 BLOOD ALKALINE PHOSPHATASE INCREASED 36 0.0014
275 POOR VENOUS ACCESS 15 0.0014
276 OXYGEN SATURATION DECREASED 81 0.0014
277 PNEUMONITIS 39 0.0014
278 SKIN INFECTION 16 0.0014
279 JAUNDICE 38 0.0014
280 SEROTONIN SYNDROME 27 0.0014
281 BRAIN FOG 22 0.0014
282 CYANOSIS 22 0.0014
283 ABNORMAL SENSATION IN EYE 6 0.0014
284 MOUTH SWELLING 8 0.0014
285 CYTOMEGALOVIRUS INFECTION 23 0.0014
286 VAGINAL DISCHARGE 14 0.0014
287 ANGIOEDEMA 61 0.0014
288 MOUTH ULCERATION 29 0.0014
289 CUTANEOUS VASCULITIS 5 0.0014
290 ASPIRATION 15 0.0014
291 CHEST DISCOMFORT 140 0.0014
292 ORAL CANDIDIASIS 18 0.0014
293 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 7 0.0014
294 ALCOHOL USE 5 0.0014
295 DRUG ERUPTION 24 0.0014
296 METABOLIC ACIDOSIS 43 0.0013
297 PANCYTOPENIA 75 0.0013
298 UPPER RESPIRATORY TRACT INFECTION 62 0.0013
299 PAIN IN JAW 38 0.0013
300 TONSILLITIS 7 0.0013
301 ODYNOPHAGIA 8 0.0013
302 SPINAL COMPRESSION FRACTURE 11 0.0013
303 SLEEP DISORDER 93 0.0013
304 DYSPEPSIA 129 0.0013
305 GASTRIC INFECTION 5 0.0013
306 FACE OEDEMA 22 0.0013
307 LIVER FUNCTION TEST INCREASED 28 0.0013
308 SEPSIS 145 0.0013
309 AUTOIMMUNE HEPATITIS 9 0.0013
310 EYELID OEDEMA 15 0.0013
311 CHOLANGITIS 8 0.0013
312 CLOSTRIDIUM DIFFICILE INFECTION 28 0.0013
313 PSEUDOMONAS INFECTION 11 0.0013
314 PRE-EXISTING CONDITION IMPROVED 8 0.0013
315 BODY TEMPERATURE INCREASED 26 0.0013
316 HYPOCALCAEMIA 24 0.0013
317 COLITIS MICROSCOPIC 6 0.0013
318 SPUTUM DISCOLOURED 12 0.0013
319 SEIZURE 146 0.0013
320 STEVENS-JOHNSON SYNDROME 28 0.0013
321 NEUROTOXICITY 22 0.0013
322 TACHYPNOEA 17 0.0012
323 PARAESTHESIA ORAL 18 0.0012
324 PRODUCT LEAKAGE 7 0.0012
325 ARTERIOSPASM CORONARY 5 0.0012
326 DERMATITIS BULLOUS 9 0.0012
327 HYPERCHOLESTEROLAEMIA 12 0.0012
328 CYSTITIS HAEMORRHAGIC 5 0.0012
329 INCOHERENT 8 0.0012
330 CONSTIPATION 269 0.0012
331 EXTRAVASATION 5 0.0012
332 PYREXIA 418 0.0012
333 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 63 0.0012
334 FEELING HOT 74 0.0012
335 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 28 0.0012
336 PNEUMONIA BACTERIAL 11 0.0012
337 PERIPHERAL SENSORY NEUROPATHY 7 0.0012
338 OESOPHAGITIS 13 0.0012
339 FEELING COLD 33 0.0012
340 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
341 INCORRECT DRUG ADMINISTRATION RATE 5 0.0012
342 DEVICE RELATED INFECTION 18 0.0012
343 LIVER FUNCTION TEST ABNORMAL 34 0.0012
344 FOOD ALLERGY 9 0.0012
345 GASTROENTERITIS VIRAL 21 0.0012
346 HEPATITIS B 7 0.0012
347 HEPATIC FAILURE 35 0.0012
348 APLASTIC ANAEMIA 6 0.0011
349 ANAEMIA 219 0.0011
350 GROIN PAIN 10 0.0011
351 CARDIOMEGALY 14 0.0011
352 BLOOD CHOLESTEROL INCREASED 53 0.0011
353 TUMOUR LYSIS SYNDROME 10 0.0011
354 HYPOXIA 40 0.0011
355 FURUNCLE 9 0.0011
356 ACUTE RESPIRATORY DISTRESS SYNDROME 20 0.0011
357 NYSTAGMUS 6 0.0011
358 RASH ERYTHEMATOUS 54 0.0011
359 SCIATICA 18 0.0011
360 PHARYNGITIS 14 0.0011
361 CANDIDA INFECTION 19 0.0011
362 OSTEOPENIA 17 0.0011
363 SWELLING OF EYELID 7 0.0011
364 GINGIVITIS 6 0.0011
365 ERYTHEMA OF EYELID 6 0.0011
366 HYDROCEPHALUS 6 0.0011
367 ACCIDENT 13 0.0011
368 HYPOTHERMIA 11 0.0011
369 MUSCLE INJURY 9 0.0011
370 UROSEPSIS 10 0.0011
371 PULMONARY EMBOLISM 103 0.0011
372 RETCHING 23 0.0011
373 INTRACRANIAL PRESSURE INCREASED 6 0.0011
374 DRY MOUTH 87 0.0011
375 DIARRHOEA HAEMORRHAGIC 10 0.0011
376 SENSATION OF FOREIGN BODY 9 0.0011
377 PALLOR 29 0.0011
378 HYPERBILIRUBINAEMIA 11 0.0011
379 RASH MACULAR 37 0.0011
380 RESPIRATORY ARREST 29 0.0011
381 WEIGHT FLUCTUATION 11 0.0011
382 DERMATITIS 22 0.0010
383 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 27 0.0010
384 SKIN HYPERPIGMENTATION 9 0.0010
385 WHEEZING 62 0.0010
386 LIPASE INCREASED 8 0.0010
387 SKIN ATROPHY 6 0.0010
388 BLOOD CREATININE INCREASED 68 0.0010
389 BRONCHIECTASIS 7 0.0010
390 SEPTIC SHOCK 45 0.0010
391 GRIP STRENGTH DECREASED 9 0.0010
392 STOMATITIS 62 0.0010
393 IMMUNOSUPPRESSION 9 0.0010
394 BACTERAEMIA 12 0.0010
395 BLOOD LACTATE DEHYDROGENASE INCREASED 16 0.0010
396 PNEUMONIA ASPIRATION 25 0.0010
397 DEFAECATION URGENCY 7 0.0010
398 BONE PAIN 58 0.0010
399 DRUG-INDUCED LIVER INJURY 31 0.0010
400 THERMAL BURN 7 0.0010
401 COUGH 276 0.0010
402 ABDOMINAL PAIN 228 0.0010
403 INCREASED UPPER AIRWAY SECRETION 5 0.0010
404 GRAFT VERSUS HOST DISEASE 7 0.0010
405 SWELLING 91 0.0010
406 CEREBRAL ISCHAEMIA 5 0.0010
407 UPPER-AIRWAY COUGH SYNDROME 8 0.0010
408 LIVER DISORDER 43 0.0010
409 MUSCULOSKELETAL CHEST PAIN 15 0.0010
410 PERSONALITY CHANGE 9 0.0010
411 MYOCARDIAL ISCHAEMIA 11 0.0010
412 INFUSION SITE EXTRAVASATION 6 0.0010
413 C-REACTIVE PROTEIN INCREASED 35 0.0010
414 EPSTEIN-BARR VIRUS INFECTION 6 0.0010
415 LETHARGY 55 0.0010
416 OROPHARYNGEAL PAIN 88 0.0009
417 PROTEINURIA 18 0.0009
418 FULL BLOOD COUNT ABNORMAL 10 0.0009
419 TRANSAMINASES INCREASED 21 0.0009
420 PNEUMONIA 305 0.0009
421 RESPIRATORY DISTRESS 26 0.0009
422 DUODENAL ULCER PERFORATION 7 0.0009
423 COVID-19 165 0.0009
424 HYPOTHYROIDISM 30 0.0009
425 FACIAL PARALYSIS 8 0.0009
426 ALOPECIA 184 0.0009
427 INTENTIONAL PRODUCT MISUSE 82 0.0009
428 DIARRHOEA 603 0.0009
429 PROCTALGIA 6 0.0009
430 RECTAL HAEMORRHAGE 40 0.0009
431 RHINORRHOEA 60 0.0009
432 BLISTER 52 0.0009
433 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 6 0.0009
434 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
435 CHOLECYSTITIS 11 0.0009
436 VITAMIN D DEFICIENCY 9 0.0009
437 PRODUCTIVE COUGH 44 0.0009
438 INTENTIONAL PRODUCT USE ISSUE 80 0.0009
439 WOUND INFECTION 10 0.0009
440 ASTHENOPIA 5 0.0009
441 ANKLE FRACTURE 14 0.0009
442 WHITE BLOOD CELL COUNT DECREASED 98 0.0009
443 OEDEMA 49 0.0009
444 APNOEA 7 0.0009
445 HEPATITIS 23 0.0009
446 CYTOPENIA 11 0.0009
447 ANAPHYLACTIC SHOCK 23 0.0009
448 COLITIS ISCHAEMIC 6 0.0009
449 ANAL INCONTINENCE 8 0.0009
450 OROPHARYNGEAL DISCOMFORT 8 0.0009
451 CHEST PAIN 164 0.0009
452 ILEUS 11 0.0009
453 CHOLECYSTITIS ACUTE 5 0.0009
454 BLOOD ALBUMIN DECREASED 7 0.0009
455 LIP DRY 8 0.0009
456 DIABETES MELLITUS 67 0.0009
457 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 9 0.0009
458 ECCHYMOSIS 6 0.0009
459 SKIN LESION 24 0.0009
460 DERMATITIS ALLERGIC 11 0.0009
461 PULMONARY MASS 13 0.0009
462 TEMPERATURE INTOLERANCE 9 0.0009
463 MIOSIS 7 0.0009
464 VOMITING 408 0.0009
465 MYDRIASIS 11 0.0009
466 GAMMA-GLUTAMYLTRANSFERASE INCREASED 19 0.0009
467 SCRATCH 9 0.0009
468 ABDOMINAL DISTENSION 89 0.0009
469 UNRESPONSIVE TO STIMULI 22 0.0009
470 PAPULE 6 0.0009
471 COLD SWEAT 15 0.0009
472 SUDDEN DEATH 9 0.0008
473 OEDEMA PERIPHERAL 103 0.0008
474 DECREASED APPETITE 196 0.0008
475 HEART RATE IRREGULAR 19 0.0008
476 EOSINOPHIL COUNT INCREASED 7 0.0008
477 CARDIO-RESPIRATORY ARREST 35 0.0008
478 BLOOD UREA INCREASED 14 0.0008
479 URTICARIA 140 0.0008
480 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
481 BLOOD CREATINE PHOSPHOKINASE INCREASED 24 0.0008
482 DIVERTICULITIS 23 0.0008
483 EPISTAXIS 62 0.0008
484 DYSPNOEA 469 0.0008
485 SKIN LACERATION 9 0.0008
486 INJECTION SITE VESICLES 5 0.0008
487 MUSCLE TWITCHING 19 0.0008
488 NAUSEA 651 0.0008
489 GENERAL PHYSICAL HEALTH DETERIORATION 95 0.0008
490 MAJOR DEPRESSION 6 0.0008
491 HYPOTENSION 164 0.0008
492 HEPATOMEGALY 8 0.0008
493 HYPERCALCAEMIA 10 0.0008
494 TOXICITY TO VARIOUS AGENTS 136 0.0008
495 INTERSTITIAL LUNG DISEASE 39 0.0008
496 HEPATIC FUNCTION ABNORMAL 30 0.0008
497 CHILLS 94 0.0008
498 TRANSIENT ISCHAEMIC ATTACK 27 0.0008
499 SOMNOLENCE 161 0.0008
500 CARDIAC ARREST 66 0.0008
501 NASAL DRYNESS 5 0.0008
502 POISONING 10 0.0008
503 HYPERGLYCAEMIA 29 0.0008
504 MICTURITION URGENCY 9 0.0008
505 HYPERTHERMIA 6 0.0008
506 CARPAL TUNNEL SYNDROME 11 0.0008
507 PULMONARY FIBROSIS 15 0.0008
508 SKIN REACTION 11 0.0008
509 URINARY TRACT INFECTION 133 0.0008
510 ROTATOR CUFF SYNDROME 10 0.0008
511 HELICOBACTER INFECTION 8 0.0008
512 ERYTHEMA 160 0.0008
513 DELIRIUM 27 0.0008
514 APHTHOUS ULCER 6 0.0008
515 VASCULITIS 9 0.0008
516 BACK PAIN 179 0.0008
517 HERPES SIMPLEX 5 0.0008
518 ASTHMA 86 0.0008
519 PNEUMOTHORAX 12 0.0008
520 CONJUNCTIVITIS 14 0.0008
521 CHROMATURIA 17 0.0008
522 PALPITATIONS 88 0.0008
523 HAEMOGLOBIN DECREASED 77 0.0007
524 HAEMATEMESIS 19 0.0007
525 MENINGITIS 5 0.0007
526 POOR QUALITY SLEEP 16 0.0007
527 SUICIDE ATTEMPT 45 0.0007
528 METASTASES TO LYMPH NODES 5 0.0007
529 ALTERED STATE OF CONSCIOUSNESS 16 0.0007
530 HEAD DISCOMFORT 13 0.0007
531 ENCEPHALOPATHY 18 0.0007
532 PERITONITIS 15 0.0007
533 PRODUCT USE IN UNAPPROVED INDICATION 178 0.0007
534 EXTRASYSTOLES 5 0.0007
535 ORAL PAIN 16 0.0007
536 HAEMODIALYSIS 6 0.0007
537 COMA 34 0.0007
538 INTESTINAL PERFORATION 8 0.0007
539 INFECTION 103 0.0007
540 DEVICE OCCLUSION 10 0.0007
541 THROMBOSIS 57 0.0007
542 VERTIGO 43 0.0007
543 SINUSITIS 72 0.0007
544 AGRANULOCYTOSIS 13 0.0007
545 ATRIAL FIBRILLATION 68 0.0007
546 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5 0.0007
547 PRURITUS 268 0.0007
548 AGITATION 51 0.0007
549 MUSCLE STRAIN 6 0.0007
550 CORONARY ARTERY DISEASE 21 0.0007
551 PARAESTHESIA 109 0.0007
552 BLOOD PRESSURE DECREASED 46 0.0007
553 HEPATIC CIRRHOSIS 13 0.0007
554 OBESITY 11 0.0007
555 MADAROSIS 8 0.0007
556 TOOTH ABSCESS 7 0.0007
557 HYPERKALAEMIA 24 0.0007
558 HYPERSENSITIVITY 127 0.0007
559 RESTLESSNESS 25 0.0007
560 PULMONARY CONGESTION 9 0.0007
561 DEPRESSED LEVEL OF CONSCIOUSNESS 27 0.0007
562 DYSURIA 25 0.0007
563 FATIGUE 528 0.0007
564 ARTHROPOD BITE 5 0.0007
565 EYE SWELLING 25 0.0007
566 PETECHIAE 7 0.0007
567 MYOSITIS 6 0.0007
568 THROAT IRRITATION 30 0.0007
569 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
570 VENTRICULAR TACHYCARDIA 11 0.0007
571 PHOTOSENSITIVITY REACTION 11 0.0007
572 HYPOPHAGIA 17 0.0007
573 HYPOAESTHESIA ORAL 10 0.0007
574 JOINT DISLOCATION 7 0.0007
575 BRONCHITIS 49 0.0007
576 LUPUS-LIKE SYNDROME 6 0.0007
577 VIRAL INFECTION 22 0.0007
578 SKIN ULCER 17 0.0007
579 RASH 286 0.0007
580 ACIDOSIS 5 0.0007
581 LIVER INJURY 16 0.0007
582 MUSCULOSKELETAL STIFFNESS 57 0.0006
583 GRAND MAL CONVULSION 6 0.0006
584 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
585 HEART RATE INCREASED 64 0.0006
586 CIRCULATORY COLLAPSE 11 0.0006
587 TENDONITIS 10 0.0006
588 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
589 CONDITION AGGRAVATED 196 0.0006
590 CYST 8 0.0006
591 RESPIRATORY FAILURE 47 0.0006
592 ACUTE MYOCARDIAL INFARCTION 19 0.0006
593 MASS 9 0.0006
594 MUSCULAR WEAKNESS 73 0.0006
595 EAR INFECTION 17 0.0006
596 NIGHTMARE 22 0.0006
597 RESPIRATORY DISORDER 19 0.0006
598 SPINAL DISORDER 6 0.0006
599 COLITIS 24 0.0006
600 RED BLOOD CELL SEDIMENTATION RATE INCREASED 7 0.0006
601 DYSPHONIA 37 0.0006
602 GASTRIC ULCER 12 0.0006
603 ABNORMAL BEHAVIOUR 25 0.0006
604 NASAL CONGESTION 37 0.0006
605 GINGIVAL PAIN 5 0.0006
606 CYSTITIS 20 0.0006
607 DEPRESSED MOOD 33 0.0006
608 ACUTE RESPIRATORY FAILURE 12 0.0006
609 HOT FLUSH 47 0.0006
610 DRUG INTOLERANCE 60 0.0006
611 ATELECTASIS 6 0.0006
612 OFF LABEL USE 543 0.0006
613 OVERDOSE 133 0.0006
614 AUTOIMMUNE DISORDER 6 0.0006
615 SCAB 7 0.0006
616 HAEMATURIA 21 0.0006
617 SEDATION 16 0.0006
618 DEMENTIA 17 0.0006
619 GASTRITIS 16 0.0006
620 HOSPICE CARE 6 0.0006
621 METASTASES TO LUNG 7 0.0006
622 RESTLESS LEGS SYNDROME 11 0.0006
623 SKIN EXFOLIATION 51 0.0006
624 PANIC ATTACK 22 0.0006
625 ABDOMINAL PAIN UPPER 124 0.0006
626 PRESCRIBED UNDERDOSE 12 0.0006
627 PRURITUS GENERALISED 13 0.0006
628 FUNGAL INFECTION 20 0.0006
629 BLOOD POTASSIUM DECREASED 18 0.0006
630 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
631 SPINAL PAIN 7 0.0006
632 NASOPHARYNGITIS 110 0.0006
633 QUALITY OF LIFE DECREASED 8 0.0006
634 SINUS CONGESTION 8 0.0006
635 HEPATIC STEATOSIS 11 0.0006
636 BLOOD IRON DECREASED 7 0.0006
637 UVEITIS 8 0.0006
638 INSURANCE ISSUE 9 0.0006
639 DEEP VEIN THROMBOSIS 38 0.0006
640 DISORIENTATION 23 0.0006
641 CARDIAC MURMUR 5 0.0006
642 ACUTE MYELOID LEUKAEMIA 9 0.0006
643 THERAPY PARTIAL RESPONDER 9 0.0006
644 BURSITIS 7 0.0006
645 RESPIRATORY TRACT INFECTION 15 0.0006
646 WOUND 16 0.0006
647 CONFUSIONAL STATE 92 0.0006
648 INCONTINENCE 6 0.0006
649 HYPERTENSION 120 0.0006
650 RESPIRATORY TRACT CONGESTION 9 0.0006
651 TREMOR 94 0.0006
652 LYMPHOPENIA 8 0.0006
653 MYALGIA 96 0.0006
654 JOINT INJURY 12 0.0006
655 BODY HEIGHT DECREASED 6 0.0006
656 CARDIOTOXICITY 5 0.0006
657 FEAR 15 0.0006
658 DYSPNOEA EXERTIONAL 21 0.0006
659 DECREASED ACTIVITY 6 0.0006
660 THROAT TIGHTNESS 15 0.0006
661 RASH PRURITIC 30 0.0006
662 BACK DISORDER 9 0.0006
663 DRUG ABUSE 46 0.0006
664 TOOTHACHE 10 0.0006
665 CARDIAC FAILURE 44 0.0005
666 ASTHENIA 206 0.0005
667 MALIGNANT NEOPLASM PROGRESSION 56 0.0005
668 COMPLETED SUICIDE 45 0.0005
669 HERPES ZOSTER 31 0.0005
670 AMNESIA 35 0.0005
671 PLATELET COUNT INCREASED 7 0.0005
672 LYMPHADENOPATHY 19 0.0005
673 NODULE 7 0.0005
674 ACUTE KIDNEY INJURY 82 0.0005
675 HAEMORRHAGE INTRACRANIAL 8 0.0005
676 FLANK PAIN 5 0.0005
677 LOSS OF CONSCIOUSNESS 68 0.0005
678 NIGHT SWEATS 17 0.0005
679 POLLAKIURIA 22 0.0005
680 HAEMATOTOXICITY 5 0.0005
681 FEELING JITTERY 10 0.0005
682 HYPERSOMNIA 15 0.0005
683 NEPHROLITHIASIS 24 0.0005
684 DRUG INTERACTION 83 0.0005
685 CHOLESTASIS 10 0.0005
686 PERICARDIAL EFFUSION 12 0.0005
687 NECK PAIN 29 0.0005
688 PRESCRIBED OVERDOSE 10 0.0005
689 DIZZINESS POSTURAL 5 0.0005
690 DIZZINESS 256 0.0005
691 IRRITABLE BOWEL SYNDROME 11 0.0005
692 PERIPHERAL SWELLING 79 0.0005
693 SKIN DISORDER 17 0.0005
694 BODY TEMPERATURE DECREASED 5 0.0005
695 LIGAMENT SPRAIN 5 0.0005
696 DYSARTHRIA 19 0.0005
697 HALLUCINATION 38 0.0005
698 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
699 MYOCLONUS 6 0.0005
700 INSOMNIA 133 0.0005
701 HYPERHIDROSIS 64 0.0005
702 VISION BLURRED 68 0.0005
703 WHITE BLOOD CELL COUNT INCREASED 19 0.0005
704 ADRENAL INSUFFICIENCY 6 0.0005
705 WEIGHT DECREASED 138 0.0005
706 INFLUENZA 55 0.0005
707 SNEEZING 11 0.0005
708 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
709 EAR DISCOMFORT 5 0.0005
710 ABNORMAL WEIGHT GAIN 6 0.0005
711 HEADACHE 303 0.0005
712 PEMPHIGUS 6 0.0005
713 SECRETION DISCHARGE 6 0.0005
714 PHOTOPHOBIA 9 0.0005
715 BLOOD PRESSURE INCREASED 73 0.0005
716 SPEECH DISORDER 25 0.0005
717 PERICARDITIS 8 0.0005
718 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
719 TYPE 2 DIABETES MELLITUS 16 0.0005
720 SKIN HAEMORRHAGE 7 0.0005
721 GASTROOESOPHAGEAL REFLUX DISEASE 38 0.0005
722 DRUG EXPOSURE DURING PREGNANCY 16 0.0005
723 PROCEDURAL PAIN 13 0.0005
724 LOWER LIMB FRACTURE 9 0.0005
725 INTENTIONAL OVERDOSE 30 0.0005
726 SCAR 8 0.0005
727 IRRITABILITY 28 0.0005
728 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
729 DEHYDRATION 62 0.0005
730 ARRHYTHMIA 22 0.0005
731 PARANOIA 8 0.0005
732 DYSTONIA 9 0.0005
733 DIPLOPIA 12 0.0005
734 SYNCOPE 46 0.0005
735 KIDNEY INFECTION 9 0.0005
736 FLATULENCE 26 0.0005
737 HAND DEFORMITY 6 0.0005
738 HIP ARTHROPLASTY 7 0.0005
739 METASTASES TO LIVER 8 0.0005
740 CONVULSION 26 0.0005
741 SINUS DISORDER 9 0.0005
742 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
743 BLOOD PRESSURE ABNORMAL 9 0.0005
744 FIBROMYALGIA 11 0.0005
745 LIMB DISCOMFORT 14 0.0005
746 RENAL IMPAIRMENT 38 0.0005
747 FOOT DEFORMITY 5 0.0005
748 DELUSION 7 0.0005
749 GAIT INABILITY 15 0.0004
750 OSTEOARTHRITIS 19 0.0004
751 THIRST 8 0.0004
752 CEREBRAL HAEMORRHAGE 16 0.0004
753 GLOSSODYNIA 10 0.0004
754 ILLNESS 46 0.0004
755 DYSPHAGIA 42 0.0004
756 MITRAL VALVE INCOMPETENCE 5 0.0004
757 URINARY INCONTINENCE 13 0.0004
758 MALAISE 192 0.0004
759 INTERNAL HAEMORRHAGE 5 0.0004
760 PERIPHERAL COLDNESS 6 0.0004
761 MEMORY IMPAIRMENT 60 0.0004
762 MYOCARDITIS 5 0.0004
763 NEOPLASM 5 0.0004
764 SHOCK 10 0.0004
765 GASTRIC HAEMORRHAGE 5 0.0004
766 BRADYCARDIA 23 0.0004
767 FLUID RETENTION 22 0.0004
768 HUNGER 6 0.0004
769 APHONIA 6 0.0004
770 CAESAREAN SECTION 5 0.0004
771 INFLAMMATION 22 0.0004
772 MANIA 7 0.0004
773 EYE PAIN 24 0.0004
774 STAPHYLOCOCCAL INFECTION 14 0.0004
775 COAGULOPATHY 7 0.0004
776 RED BLOOD CELL COUNT DECREASED 12 0.0004
777 MUSCLE SPASMS 77 0.0004
778 SLEEP APNOEA SYNDROME 8 0.0004
779 MUSCLE RIGIDITY 5 0.0004
780 PRODUCT USE ISSUE 78 0.0004
781 HYPERTHYROIDISM 6 0.0004
782 DRY SKIN 55 0.0004
783 NOCTURIA 5 0.0004
784 ORAL HERPES 8 0.0004
785 DISCOMFORT 25 0.0004
786 RHABDOMYOLYSIS 17 0.0004
787 HYPOAESTHESIA 61 0.0004
788 UPPER LIMB FRACTURE 8 0.0004
789 RENAL FAILURE ACUTE 17 0.0004
790 HEART RATE DECREASED 14 0.0004
791 HAEMATOCHEZIA 22 0.0004
792 MIGRAINE 38 0.0004
793 CARDIOVASCULAR DISORDER 10 0.0004
794 ANXIETY 112 0.0004
795 PHARYNGEAL OEDEMA 6 0.0004
796 URINARY RETENTION 13 0.0004
797 THYROID DISORDER 6 0.0004
798 ANGINA PECTORIS 11 0.0004
799 INTENTIONAL DRUG MISUSE 8 0.0004
800 ROAD TRAFFIC ACCIDENT 16 0.0004
801 PULMONARY OEDEMA 17 0.0004
802 THERAPY NON-RESPONDER 17 0.0004
803 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 68 0.0004
804 EATING DISORDER 8 0.0004
805 JOINT RANGE OF MOTION DECREASED 5 0.0004
806 LOCALISED INFECTION 9 0.0004
807 HYPOGLYCAEMIA 18 0.0004
808 MUSCLE TIGHTNESS 6 0.0004
809 CEREBRAL INFARCTION 9 0.0004
810 INCORRECT DOSE ADMINISTERED 84 0.0004
811 IMPAIRED GASTRIC EMPTYING 5 0.0004
812 EYE DISORDER 12 0.0004
813 CORONARY ARTERY OCCLUSION 5 0.0004
814 PAIN IN EXTREMITY 107 0.0004
815 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
816 ERUCTATION 7 0.0004
817 WEIGHT INCREASED 81 0.0004
818 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
819 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
820 MEDICATION ERROR 20 0.0004
821 GASTROINTESTINAL HAEMORRHAGE 30 0.0004
822 COORDINATION ABNORMAL 5 0.0004
823 BURNING SENSATION 25 0.0004
824 ARTHRITIS 28 0.0004
825 HAEMATOCRIT DECREASED 7 0.0004
826 NERVOUS SYSTEM DISORDER 11 0.0004
827 HEPATIC ENZYME INCREASED 24 0.0004
828 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
829 BALANCE DISORDER 30 0.0003
830 MULTI-ORGAN FAILURE 6 0.0003
831 ARTHRALGIA 144 0.0003
832 FEEDING DISORDER 7 0.0003
833 INTESTINAL OBSTRUCTION 13 0.0003
834 DEAFNESS 9 0.0003
835 CONTUSION 33 0.0003
836 OSTEOPOROSIS 14 0.0003
837 RIB FRACTURE 7 0.0003
838 LABORATORY TEST ABNORMAL 10 0.0003
839 OCULAR HYPERAEMIA 16 0.0003
840 GALLBLADDER DISORDER 6 0.0003
841 COLON CANCER 5 0.0003
842 IMMUNODEFICIENCY 5 0.0003
843 PAIN OF SKIN 9 0.0003
844 LIMB INJURY 9 0.0003
845 EPILEPSY 10 0.0003
846 TINNITUS 15 0.0003
847 INJECTION SITE URTICARIA 8 0.0003
848 JOINT SWELLING 39 0.0003
849 AGEUSIA 8 0.0003
850 CATARACT 19 0.0003
851 FALL 106 0.0003
852 MELAENA 7 0.0003
853 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
854 SUICIDAL IDEATION 29 0.0003
855 RENAL FAILURE 42 0.0003
856 HEAD INJURY 10 0.0003
857 PAIN 194 0.0003
858 TOOTH DISORDER 7 0.0003
859 RASH GENERALISED 8 0.0003
860 BLOOD POTASSIUM INCREASED 5 0.0003
861 ECZEMA 16 0.0003
862 MYELOSUPPRESSION 11 0.0003
863 MUSCULOSKELETAL PAIN 16 0.0003
864 JOINT STIFFNESS 8 0.0003
865 AGGRESSION 15 0.0003
866 EYE PRURITUS 10 0.0003
867 INTENTIONAL SELF-INJURY 6 0.0003
868 TASTE DISORDER 6 0.0003
869 DYSKINESIA 12 0.0003
870 DEPRESSION 67 0.0003
871 PRODUCT PRESCRIBING ERROR 7 0.0003
872 MOOD ALTERED 8 0.0003
873 DEATH 252 0.0003
874 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
875 MENTAL STATUS CHANGES 8 0.0003
876 FEELING ABNORMAL 69 0.0003
877 ABDOMINAL DISCOMFORT 48 0.0003
878 EOSINOPHILIA 5 0.0003
879 SKIN DISCOLOURATION 13 0.0003
880 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
881 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 20 0.0003
882 DRY EYE 14 0.0003
883 GASTROINTESTINAL DISORDER 25 0.0003
884 FAECES DISCOLOURED 6 0.0003
885 TREATMENT NONCOMPLIANCE 15 0.0003
886 UNDERDOSE 20 0.0003
887 PSORIATIC ARTHROPATHY 11 0.0003
888 BLOOD GLUCOSE ABNORMAL 5 0.0003
889 HAEMATOMA 7 0.0003
890 EXPOSURE VIA SKIN CONTACT 7 0.0003
891 RASH PAPULAR 6 0.0003
892 PREMATURE BABY 8 0.0003
893 LUNG DISORDER 13 0.0003
894 CHRONIC KIDNEY DISEASE 20 0.0003
895 INCREASED APPETITE 5 0.0003
896 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
897 PLASMA CELL MYELOMA 10 0.0003
898 INJURY 18 0.0003
899 PSORIASIS 33 0.0003
900 DISEASE RECURRENCE 12 0.0003
901 ARTHROPATHY 14 0.0003
902 GAIT DISTURBANCE 48 0.0003
903 MOBILITY DECREASED 18 0.0003
904 BLOOD PRESSURE FLUCTUATION 6 0.0002
905 MOVEMENT DISORDER 8 0.0002
906 HAEMORRHAGE 26 0.0002
907 HOSPITALISATION 38 0.0002
908 ILL-DEFINED DISORDER 15 0.0002
909 PANCREATITIS 13 0.0002
910 INJURY ASSOCIATED WITH DEVICE 5 0.0002
911 CHOLELITHIASIS 8 0.0002
912 IMPAIRED HEALING 8 0.0002
913 KNEE ARTHROPLASTY 5 0.0002
914 SKIN BURNING SENSATION 17 0.0002
915 ABDOMINAL PAIN LOWER 6 0.0002
916 HALLUCINATION, VISUAL 5 0.0002
917 MATERNAL EXPOSURE DURING PREGNANCY 21 0.0002
918 COGNITIVE DISORDER 11 0.0002
919 ADVERSE DRUG REACTION 21 0.0002
920 MULTIPLE SCLEROSIS RELAPSE 16 0.0002
921 APHASIA 7 0.0002
922 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
923 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
924 CEREBROVASCULAR ACCIDENT 39 0.0002
925 BLOOD GLUCOSE DECREASED 11 0.0002
926 DYSGEUSIA 17 0.0002
927 ANHEDONIA 6 0.0002
928 FEMUR FRACTURE 7 0.0002
929 EXPOSURE DURING PREGNANCY 14 0.0002
930 CARDIAC FAILURE CONGESTIVE 18 0.0002
931 RHEUMATOID ARTHRITIS 25 0.0002
932 ABNORMAL DREAMS 6 0.0002
933 HYPOACUSIS 9 0.0002
934 PRODUCT DOSE OMISSION ISSUE 61 0.0002
935 GASTRIC DISORDER 7 0.0002
936 DISTURBANCE IN ATTENTION 11 0.0002
937 ABASIA 5 0.0002
938 COLITIS ULCERATIVE 9 0.0002
939 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
940 ADVERSE EVENT 18 0.0002
941 ERECTILE DYSFUNCTION 5 0.0002
942 LUNG NEOPLASM MALIGNANT 8 0.0002
943 EYE IRRITATION 11 0.0002
944 INJECTION SITE BRUISING 15 0.0002
945 ACNE 14 0.0002
946 INFLUENZA LIKE ILLNESS 15 0.0002
947 NEOPLASM MALIGNANT 12 0.0002
948 VISUAL IMPAIRMENT 22 0.0002
949 INTENTIONAL DOSE OMISSION 5 0.0002
950 MYOCARDIAL INFARCTION 30 0.0002
951 UNEVALUABLE EVENT 13 0.0002
952 BLINDNESS 7 0.0002
953 RENAL DISORDER 8 0.0002
954 CARDIAC DISORDER 16 0.0002
955 PRODUCT DOSE OMISSION 11 0.0002
956 MULTIPLE SCLEROSIS 8 0.0002
957 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
958 WRONG TECHNIQUE IN DRUG USAGE PROCESS 6 0.0002
959 THERAPEUTIC RESPONSE DECREASED 10 0.0002
960 ACCIDENTAL OVERDOSE 6 0.0002
961 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0002
962 MOOD SWINGS 5 0.0002
963 PRODUCT SUBSTITUTION ISSUE 9 0.0002
964 LACTIC ACIDOSIS 5 0.0002
965 DRUG INEFFECTIVE 202 0.0002
966 BREAST CANCER 14 0.0002
967 ABORTION SPONTANEOUS 6 0.0001
968 ANGER 5 0.0001
969 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 28 0.0001
970 DEVICE DISLOCATION 6 0.0001
971 CRYING 5 0.0001
972 DERMATITIS ATOPIC 7 0.0001
973 ACCIDENTAL EXPOSURE TO PRODUCT 13 0.0001
974 SURGERY 7 0.0001
975 DRUG WITHDRAWAL SYNDROME 10 0.0001
976 INJECTION SITE ERYTHEMA 14 0.0001
977 INJECTION SITE HAEMORRHAGE 9 0.0001
978 BLOOD GLUCOSE INCREASED 21 0.0001
979 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
980 INJECTION SITE PRURITUS 7 0.0001
981 INJECTION SITE SWELLING 8 0.0001
982 INJECTION SITE PAIN 31 0.0001
983 THERAPY INTERRUPTED 7 0.0001
984 NERVOUSNESS 5 0.0001
985 EMOTIONAL DISTRESS 11 0.0001
986 PRODUCT QUALITY ISSUE 12 0.0001
987 INJECTION SITE REACTION 6 0.0001
988 NO ADVERSE EVENT 15 0.0001
989 DRUG DOSE OMISSION 13 0.0001
990 PROSTATE CANCER 6 0.0001
991 TREATMENT FAILURE 6 0.0001
992 DEVICE MALFUNCTION 5 0.0001
993 DEVICE ISSUE 6 0.0001
994 DRUG DEPENDENCE 8 0.0000